A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia
Clinical trial NCT02028455 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02028455
- Sponsor
- Seattle Children's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-11
- Primary completion
- 2021-08-10
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.